Revance Therapeutics Inc (NASDAQ: RVNC) stock suffered a major decline of -17.0% on 11/9/23. The shares closed at $6.91. The stock has been extremely weak relative to the market over the last nine months and […]
Amicus Therapeutics Inc (NASDAQ: FOLD) stock suffered a major decline of -12.2% on 11/9/23. The shares closed at $9.98. The stock has been strong relative to the market over the last nine months but has […]
Full House Resorts Inc (NASDAQ: FLL) stock enjoyed a major increase of 18.7% on 11/9/23. The shares closed at $4.64. The stock has risen 28.9% during the last week but has been extremely weak relative […]
Clearfield Inc (NASDAQ: CLFD) has reported E.P.S. of $0.16 for its fourth fiscal quarter (ending September 30) versus $1.22 for the same period a year ago — a decline of -87%. Relative to the consensus […]
On 11/9/23, CareDx Inc (NASDAQ: CDNA) stock enjoyed a major increase of 13.9%, closing at $7.21. Relative to the market the stock has been extremely weak over the last nine months but has risen 33.3% […]
Middlesex Water Co (NASDAQ: MSEX) has reported E.P.S. of $0.56 for its third fiscal quarter (ending September 30) versus $0.81 for the same period a year ago — a decline of -31%. This result fell […]
Mastech Digital Inc (NYSEAMERICAN: MHH) stock closed at $9.81 on 11/9/23 after a major increase of 11.6%. Relative to the market the stock has been weak over the last nine months but has risen 4.5% […]
Cryoport Inc (NASDAQ: CYRX) stock enjoyed a major increase of 10.0% on 11/9/23. The shares closed at $11.30. The stock has been extremely weak relative to the market over the last nine months but has […]
The Joint Corp (NASDAQ: JYNT) stock closed at $7.37 on 11/9/23 after a major decline of -10.2%. The stock has declined -2.1% during the last week and has been extremely weak relative to the market […]
Wolverine World Wide Inc. (NYSE: WWW) has reported E.P.S. of $0.11 for its third fiscal quarter (ending September 30) versus $0.49 for the same period a year ago — a decline of -78%. However, this […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research